Document:

Ex 10.52 CEO Release and Agt 2013 03 31

Exhibit 10.52

AGREEMENT AND RELEASES
THIS AGREEMENT is dated March 31, 2013 by and between Michael S. Gunter (“Mr. Gunter”), who resides in Winston-Salem, North Carolina, and Arrhythmia Research Technology, Inc. (“ART”), with its principal place of business located in Fitchburg, Massachusetts.
WHEREAS, Mr. Gunter was employed as the Interim President and Chief Executive Officer of ART and its subsidiaries, Micron Products, Inc. and RMDDxUSA Corp. (collectively referred to herein as “the Companies”), which employment ended on March 31, 2013;
WHEREAS, Mr. Gunter was a member of the Companies' boards of directors until March 25, 2013, on which date he resigned from those positions;
WHEREAS, ART is willing to provide to Mr. Gunter a final payment (the “Completion Payment”) in connection with the end of his employment by the Companies; and
WHEREAS, Mr. Gunter acknowledges that the Completion Payment is being provided to him by ART is in addition to any other payment of benefits to which he might otherwise be entitled as a result of the end of his employment;
NOW, THEREFORE, in consideration of the foregoing and of the agreements hereinafter set forth, the parties hereto mutually agree as follows:
1.    Subject to the provisions of this Agreement, ART shall pay Mr. Gunter the Completion Payment, the total gross amount of which is Twenty Thousand Dollars ($20,000.00), in one lump sum.  That payment shall be subject to and reduced by regular payroll taxes and withholding.  ART shall make that payment within seven (7) days following the expiration of the seven-day revocation period set forth in Section 6 below.  The payment of the Completion Payment to Mr. Gunter shall be a complete and unconditional payment, accord and/or satisfaction with respect to all obligations and liabilities of the Companies to Mr. Gunter, including, without limitation, all claims for back wages, salary, vacation pay, incentive pay, bonuses, reimbursement of expenses, any and all other forms of compensation or benefits, attorneys' fees, or other costs or sums.
2.    The Companies will not oppose any claim by Mr. Gunter to obtain unemployment compensation benefits.
3.    It is understood and agreed by Mr. Gunter that this Agreement and any payment made or action taken pursuant to this Agreement do not constitute and are not to be construed as an admission by the Companies of liability of any kind to Mr. Gunter or that any action taken with respect to Mr. Gunter was unlawful or wrongful.
4.    In consideration of the foregoing, Mr. Gunter, for himself, his heirs, administrators, executors and assigns, with full understanding of the content and legal effect of this release, hereby releases, discharges and covenants not to sue or commence or prosecute proceedings against the Companies or any of their related or affiliated entities, and its or their officers, partners, directors, shareholders, members, agents, employees, attorneys, successors and assigns (individually and in their representative capacities, all of the foregoing being referred to herein as the “Releasees”), from and with respect to any and all debts, claims, demands, damages and causes of action of any kind whatsoever, whether known or unknown or unforeseen, which Mr. Gunter now has or ever had against the Releasees, arising to the date of this Agreement, including without limitation on the foregoing, those arising out of or in any manner relating to Mr. Gunter's employment by the Companies, or the end of such employment, or those arising from any other dealings with Releasees, including, without limitation, any claim for reinstatement, back or future pay, bonuses, fringe benefits, medical expenses, relocation expenses, outplacement services, attorneys' fees, expenses, or compensatory, consequential or exemplary damages; including, but not limited to, any claim, complaint, charge or lawsuit under any of the following statutes or orders:  Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Age Discrimination in Employment Act of 1967 (ADEA), the Older Workers Benefit Protection Act (OWBPA), the Equal Pay Act of 1963, the Americans with Disabilities Act, the Employee Retirement 

X-3 Page 1

Exhibit 10.52

Income Security Act, the Rehabilitation Act of 1973, Executive Order 11246, the Massachusetts Fair Employment Practices Act (General Laws Ch.151B), the Massachusetts Equal Pay Act (General Laws Ch.149, §105A), the Massachusetts Civil Rights Act (General Laws Ch.12, §§11H, 11I), the Massachusetts Equal Rights Act (General Laws Ch.93, §§102, 103), and state and federal laws regarding the payment of wages laws, including but not limited to the Fair Labor Standards Act (29 U.S.C. §201, et seq.), M.G.L. Chapter 149, Section 148, et. seq. and M.G.L. Chapter 151, Section 1, et seq., and any other state, federal or municipal law, statute, public policy, order, or regulation affecting or relating to the claims or rights of employees; including any and all claims and suits in tort or contract.
The recitation of specific claims in the second and third paragraphs of this Section is without prejudice to the general release in the first paragraph of this Section and is not intended to limit the scope of the general release.
This Release does not apply to any claims arising solely after the execution of this Agreement or to any claims arising from a breach of this Agreement.
5.    In consideration of the foregoing, the Companies and their officers and directors release and forever discharge Mr. Gunter from and with respect to any and all debts, claims, demands, damages and causes of action of any kind whatsoever, whether known or unknown or unforeseen, which the Companies and/or their officers and directors now have or ever had against Mr. Gunter, arising to the date of this Agreement, including without limitation on the foregoing those arising out of or in any manner relating to Mr. Gunter's employment by the Companies or the end of his employment by the Companies, or those arising from any other dealings between the Companies and Mr. Gunter, and including any and all claims and suits in contract or tort; up to and including the date of this Agreement.  This release of claims shall not include any claims (a) regarding conversion, embezzlement, fraud or theft, or (b) arising solely after the execution of this Agreement, or (c) arising from a breach of this Agreement.
6.    Waiver of Rights and Claims Under the ADEA.  Since Mr. Gunter is 40 years of age or older, he is hereby informed, in writing, that he has or may have specific rights and/or claims under the Age Discrimination in Employment Act of 1967, as amended (ADEA).
(a)No Waiver of Claims Arising after Execution of Agreement.  Mr. Gunter understands and agrees that he is not waiving any rights or claims under the ADEA that may arise after the date this Agreement is executed.
(b)Knowing and Voluntary.  Mr. Gunter agrees that he has carefully read and fully understands all of the provisions of this Agreement, and that he knowingly and voluntarily agrees to all of the terms set forth in this Agreement.  Mr. Gunter acknowledges that in entering into this Agreement, he is not relying on any representation, promise or inducement made by ART or its attorneys, with the exception of those promises described in this document.  
(c)Review.  Mr. Gunter understands that he has twenty-one (21) days in which to consider this Agreement prior to signing it, but may waive all or part of the review period if he chooses.  Mr. Gunter acknowledges that any changes to this Agreement, material or otherwise, do not restart the 21-day review period.
(d)Revocation.  Mr. Gunter understands further that, once he has signed this Agreement, he has seven (7) days in which to revoke it.  Mr. Gunter understands that such seven‐day period is mandatory and may not be waived.  Mr. Gunter understands and agrees that any notice of revocation he may wish to make must be in writing and received by ART's Chairman of the Board, E.P. Marinos, within the seven-day revocation period.  Mr. Gunter further understands that the Agreement does not become effective or enforceable and that no payment will be made under the Agreement until the seven-day revocation period has expired.  
(e)Effective Date.  The Effective Date of this Agreement will be the eighth day after Mr. Gunter signs it.  If the ART does not receive Mr. Gunter's written notice that he is exercising his right of 

X-3 Page 2

Exhibit 10.52

revocation within the seven-day revocation period, the Agreement will automatically become effective as of the Effective Date.
7.    Mr. Gunter currently holds options to purchase 10,000 shares of common stock of ART at a purchase price of $5.73 per share, which options vest over a five year period beginning on June 3, 2011, pursuant to the 2010 Equity Incentive Plan (the “Plan”).  As of the date hereof, 2,000 options are vested, and 8,000 options remain unvested.  Mr. Gunter relinquishes all rights to his unvested options and agrees that the vested options shall expire June 30, 2013, which is three months from Mr. Gunter's last day of employment and association with ART, pursuant to Section 7(c) of the Plan.  
8.    Mr. Gunter is aware that the Companies develop and utilize, and that he has had access to, valuable technical and nontechnical trade secrets and confidential information including, but not limited to, knowledge, information and materials about the Companies' trade secrets, methods of operation, products, manufacturing processes, customer lists, customers or clients, suppliers, services, know-how, software development, business plans and confidential information about financial, marketing, pricing, compensation and other proprietary matters relating to ART, all of which constitutes a valuable part of the Companies' assets, which the Companies seek to protect.  Accordingly, Mr. Gunter shall not at any time disclose or make known to any person (other than as may be required by law), or use for his own or another's account or benefit, any such confidential information, whether or not developed, devised or otherwise created in whole or in part by the efforts of Mr. Gunter.  This Agreement shall not prohibit Mr. Gunter from using any general skills and knowledge which he acquired during his employment with ART.
9.    Mr. Gunter represents and warrants that he has returned to ART any and all property of ART, including any files, books, manuals, keys, software, files, documents or equipment, which was in his possession, custody or control.  Mr. Gunter also represents and warrants that he has deleted any and all software and electronically-stored data which is the property of ART and which may be contained on his home computer.
10.    Mr. Gunter agrees not to disclose the existence, provisions, terms or conditions of this Agreement to any person, unless required by law or compelled by legal process, except that disclosure may be made by Mr. Gunter to his immediate family, attorney and/or tax advisor and/or as may be necessary for him to seek unemployment benefits.  The continued confidentiality of this Agreement and its terms is of the essence.
11.    Mr. Gunter agrees not to take any action or make any statement, written or oral, which (1) disparages or criticizes the Companies (including, without limitation, their management, directors, investors or any other parties involved in a business relationship with the Companies), or (2) disparages or criticizes the Companies' practices.  For purposes of this paragraph, such prohibited actions or statements include, without limitation, any action or statement that would (a) harm the reputation of the Companies with its current and prospective customers, distributors, suppliers, other business partners or the public; or (b) interfere with existing contractual or employment relationships with current and prospective customers, suppliers, distributors, other business partners or the Companies' employees.  The Companies agree to instruct their boards of directors, senior managers and executive officers not to make any disparaging, critical or otherwise detrimental comments to any person or entity concerning Mr. Gunter; provided, however, that nothing in this provision shall preclude the Companies, their boards of directors, senior managers and/or executive officers from providing truthful information or testimony concerning Mr. Gunter as may be required by law or regulation.  
12.    This Agreement shall be binding upon Mr. Gunter, ART and their respective heirs, administrators, representatives, executors, successors and assigns and shall inure to the benefit of Mr. Gunter, ART and the Releasees and each of them, and to their respective heirs, administrators, representatives, executors, successors and assigns.

X-3 Page 3

Exhibit 10.52

13.    If any portion or provision of this Agreement is held invalid or unenforceable, the remainder of the Agreement will be deemed severable, will not be affected, and will remain in full force and effect.  
14.    Each of the Parties agrees that he or it has carefully read and fully understands all of the provisions of this Agreement, and that he or it knowingly and voluntarily agrees to all of the terms set forth in this Agreement.  Mr. Gunter acknowledges that in entering into this Agreement, he is not relying on any representation, promise or inducement made by ART or its attorneys, with the exception of those promises described in this document.
15.    This Agreement shall in all respects be interpreted, enforced and governed by and under the laws of the Commonwealth of Massachusetts without reference to its conflict of laws provisions.
16.    Opportunity to Consult Legal Counsel.  The Parties agree that by this Agreement they have been advised, in writing, to consult with legal counsel, or any other person of their choosing, before signing the Agreement, and acknowledge that they have so consulted.  Mr. Gunter acknowledges that he has not been subjected to any undue or improper influence interfering with the exercise of his free will in deciding whether to consult with counsel prior to his signing this Agreement.  
 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as an instrument under seal, as of the day and year first above written.

WITNESSES:                   ARRHYTHMIA RESEARCH TECHNOLOGY, INC.
        By /s/ E.P. Marinos
             E. P. Marinos
              Chairman of the Board
                        
          Dated:  April 2, 2013

/s/ Michael S. Gunter
Michael S. Gunter

                                Dated:  April 1, 2013

X-3 Page 4Ex 10.53 CEO Agreement 2013 04 01

Exhibit 10.53

EMPLOYMENT AGREEMENT

THIS AGREEMENT is made and entered into as of the 28th of March, 2013, by and between Arrhythmia Research Technology, Inc. (“ART”), with its principal place of business located in Fitchburg, Massachusetts, and Salvatore Emma, Jr. (“Employee”), who resides in Shirley, Massachusetts.  ART and Employee are collectively referred to herein as the “Parties.”

WHEREAS, ART desires to retain the services of Employee as President and Chief Executive Officer of ART and its subsidiaries, Micron Products, Inc. (“Micron”) and RMDDxUSA Corp. (collectively referred to herein as “the Companies”), and Employee desires to be employed by ART in such capacity, all upon the terms and subject to the conditions set forth in this Agreement.

NOW, THEREFORE, in consideration of the recitals and the mutual covenants and undertakings herein, each party agrees as follows:

1.    Employment and Duties.  ART hereby agrees to employ Employee, and Employee hereby accepts employment, as President and Chief Executive Officer of the Companies, upon the terms and conditions hereinafter set forth, both Parties expressly revoking any and all prior employment agreements between them.  In his capacity as President and Chief Executive Officer, Employee, to the best of his abilities, shall be responsible for performing the duties commensurate with his position.  Employee shall report to ART's Board of Directors (the “Board”), and Employee agrees to perform such duties as the Board may assign to him.

Employee hereby represents and warrants that he is not now subject to any agreement which is or would be inconsistent or in conflict with his obligations hereunder.

2.    Exclusive Services.  Employee agrees that he will, during the employment term, devote his entire working time, attention and best efforts to the performance of the duties as aforesaid and to the business and interests of the Companies, and he shall perform such duties as may be assigned to him ably, faithfully and diligently.  Employee shall not at any time or in any manner, either directly or indirectly, be involved in any other occupation while he is employed by ART unless agreed to specifically by ART's Board.  

3.    Term of Employment.  The period of Employee's employment under this Agreement shall commence as of April 1, 2013, and terminate on December 31, 2013, unless earlier terminated pursuant to the terms hereof.  

4.    Compensation.

(a)  Salary.  As compensation for the services to be rendered by Employee under this Agreement, ART agrees to pay, and Employee agrees to accept, a base salary at the annualized rate of $225,000.00, payable in accordance with the Company's regular payroll practices, subject to withholding and other applicable taxes.  

(b)  Bonus.  Employee shall be eligible to receive a discretionary performance bonus during the term of this Agreement.  The specific goals criteria for earning such bonus will be mutually agreed upon by the Parties as soon as possible after the Parties' execution of this Agreement.

All of Employee's compensation is subject to deductions for regular payroll taxes and withholding, as required by State and Federal law, as well as other deductions that Employee authorizes.

(c)  Fringe Benefits.  Employee also shall be entitled to the following benefits in 

X-4 Page 1

Exhibit 10.53

each year of this Agreement:

(i)  Employee shall be eligible to participate in Micron's various benefit plans (including health, dental, life, disability and retirement) on the same basis as Micron's other employees; and

(ii)  Employee shall be eligible to receive Micron's various paid time off benefits (including paid vacations and holiday) on the same basis as Micron's other employees.

(d)  Stock Options.  Employee shall be issued options to purchase 15,000 shares of ART's common stock pursuant to ART's 2010 Equity Incentive Plan, subject to annual vesting, as set forth in a separate Grant Agreement.

5.    Confidentiality.  Employee is aware that the Companies develop and utilize, and that he has had and will continue to have, access to valuable technical and nontechnical trade secrets and confidential information including, but not limited to, knowledge, information and materials about the Companies' trade secrets, mailing lists, methods of operation, advertiser lists, advertisers, customer lists, customers or clients, products, services, know-how, business plans and confidential information about financial, marketing, pricing, compensation and other proprietary matters relating to the Companies which are not in the public domain (“Confidential Information”), all of which constitutes a valuable part of the assets of the Companies which the Companies seeks to protect.

Accordingly, Employee shall not at any time during or after the termination of his employment by the Companies for any reason, reveal, disclose or make known to any person (other than as may be required by law or in the performance of his duties), or use for his own or another's account or benefit, any such Confidential Information, whether or not developed, devised or otherwise created in whole or in part by the efforts of Employee.

Employee represents and warrants that he has not revealed, disclosed or made known to any person (other than as may be required by law or in the performance of his duties), or used for his own or another's account or benefit, any such Confidential Information, whether or not developed, devised or otherwise created in whole or in part by the efforts of Employee.

Upon cessation of Employee's employment, no documents, records or other matter or information belonging to the Companies, whether prepared by Employee or otherwise, and relating in any way to the business of the Companies, shall be taken or kept by Employee without the written consent of the Companies.
6.    Non-Competition.  Employee acknowledges that, in the course of his employment by ART, he will have access to the Companies' Confidential Information; and he will be intimately and directly involved in developing and maintaining the Companies' goodwill and serving the Companies' customers and prospective customers.  Accordingly, Employee agrees that during his employment by ART and for a period of one (1) year after such employment has ceased for any reason, Employee shall not, without the prior written consent of ART:
     (a)  directly or indirectly engage in, assist or have an interest in (whether as proprietor, partner, investor, stockholder, officer, director of any type of principal), or enter the employment of or act as an agent for or advisor or consultant to, any person, firm, partnership, association, corporation, business organization, entity or enterprise which is, or is about to become, directly or indirectly engaged in any business which is directly or indirectly competitive with any of the Companies; provided that Employee may own less than 

X-4 Page 2

Exhibit 10.53

five percent (5%) of the outstanding equity securities of a corporation that is engaged in such a competitive business if the equity securities of such corporation are publicly traded and registered under the Securities Exchange Act of 1934; and
(b)  directly or indirectly solicit or accept any business substantially similar to that done by any of the Companies from any person, company, firm or organization, or any affiliate of the foregoing, which is or was a customer or active prospect of any of the Companies during the two (2) year period prior to the end of Employee's employment at ART, for or on account of any individual, business enterprise, firm, partnership, association or corporation other than the Companies; or

(c)  directly or indirectly solicit the employment of, entice away, or in any other manner persuade or attempt to persuade any person employed by any of the Companies to leave such employment.

7.    Innovations.

(a)  Employee hereby assigns, transfers and conveys to ART and its successors and assigns the entire right, title, and interest in any and all inventions, processes, procedures, systems, discoveries, designs, configurations, technology, works of authorship, trade secrets and improvements (whether or not they are made, conceived or reduced to practice during working hours or using any of the Companies' data or facilities) (collectively, “Innovations”) which Employee makes, authors, conceives, reduces to practice or otherwise acquires during any period of his/her employment by ART (either solely or jointly with others), and which are related to the Companies' present or planned business, the Companies' services or products, and any and all patents, copyrights, trademarks, trade names and applications therefor, in the United States and elsewhere, relating thereto.  The Innovations shall be the sole property of ART and shall at all times be held by Employee in a fiduciary capacity for the sole benefit of ART.
(b)  All such Innovations that consist of works of authorship capable of protection under copyright laws shall be prepared by Employee as works made for hire, with the understanding that ART shall own all of the exclusive rights to such works of authorship under the United States copyright law and all international copyright conventions and foreign laws.  The foregoing notwithstanding, to the extent that any such Innovations is not deemed a work made for hire, Employee hereby assigns to ART the entire right, title, and interest in such Innovations and any and all patents, copyrights, trademarks, trade names and applications therefor, in the United States and elsewhere, relating thereto.
(c)  Employee shall maintain adequate and current written records of all such Innovations, which shall be available to and remain the sole property of ART at all times.  Employee shall promptly disclose to ART the details of any and all such Innovations and shall provide ART with all information relative thereto.  Employee, without further compensation, shall fully cooperate with and assist ART in obtaining and enforcing for its own benefit patents and copyright registrations on and in respect of such Innovations in all countries in all ways that ART may request, to secure and enjoy the full benefits and advantages of such Innovations, including executing any and all documents that ART deems necessary to obtain, maintain, and/or enforce its rights in such Innovations and providing any testimony required to obtain, maintain, and/or enforce such Innovations.  Employee agrees, for himself, and his heirs, legal representatives and assigns, without further compensation, to execute further assignments and other lawful documents as ART may reasonably request to effectuate fully this assignment. Employee understands that his obligations under this section shall continue after the termination of his employment by ART.    

8.    Injunctive Relief.  Employee acknowledges that the restrictions contained in paragraphs 5, 6 and 7 above, in view of the nature of the business in which the Companies are engaged, are reasonable and necessary to protect the legitimate interests of the Companies.  Employee understands that the remedies at 

X-4 Page 3

Exhibit 10.53

law for his violation of any of the covenants or provisions of paragraphs 5, 6 or 7 may be inadequate, that such violations may cause irreparable injury within a short period of time, and that the Companies shall be entitled to seek preliminary injunctive relief and other injunctive relief against such violation.  Such injunctive relief shall be in addition to, and in no way in limitation of, any and all other remedies the Companies shall have in law and equity for the enforcement of those covenants and provisions.  

9.    Termination for Cause. This Agreement may be terminated by ART for cause.  No compensation shall be paid or other benefits furnished to Employee after termination for cause.  Such a termination shall be effective immediately upon written notice being issued to Employee.  “Cause” means  (i) willful and deliberate misconduct by Employee, such as being under the influence of drugs or alcohol on the job, dishonesty, misappropriation of assets, insubordination or refusal to follow reasonable directives and other misconduct of comparable magnitude and kind; (ii) willful neglect of duty or other material breach of this Agreement by Employee; (iii) commission of any act of fraud involving ART, involvement in any material conflict of interest or self-dealing involving ART, or conviction of a felony or any offenses involving moral turpitude or any criminal offense involving ART; (iv) any act or omission by Employee which has a material adverse effect on the business activities, financial condition, affairs or reputation of ART; (v) violation of any of ART's policies or (vi) Employee's unsatisfactory job performance as determined in good faith by ART's Board.

10.    Termination Other Than for Cause.

(a)  Death or Disability.  If Employee dies or becomes totally disabled during the term of this Agreement, Employee's employment and salary shall terminate at the end of the month during which death or total disability occurs, and no other compensation or benefits shall be paid to Employee.  For the purposes of this Agreement, Employee shall be deemed to be “totally disabled” if he has been unable to perform his duties by reason of medical condition for 90 days in any 365-day period, all as determined in good faith by ART's Board.

(b)  Resignation.  Notwithstanding any other provision of this Agreement, Employee shall have the right to terminate this Agreement, without cause, upon thirty (30) days' written notice to the Chairman of ART's Board.  Upon such notice of termination, no further compensation or benefits, other than payment for the 30 day notice period, shall be paid to Employee.

11.    Mediation/Arbitration of Disputes.   In the event of a dispute between the Parties, Employee and ART agree to work cooperatively to resolve the dispute amicably at appropriate, mutually determined management levels.  In the event that a resolution at such management levels does not occur, either party may submit the dispute to mediation.  Both Parties shall agree on one mediator and participate in said mediation in good faith.  If the matter has not been resolved pursuant to mediation within sixty (60) days of the commencement of such procedure, which may be extended by mutual agreement of the Parties, the dispute shall be settled by final and binding arbitration in Worcester, Massachusetts in accordance with the rules then prevailing of the American Arbitration Association.  Judgment upon the award rendered by the arbitrators may be entered in any court of competent jurisdiction, and each party shall bear his or its own costs, including attorneys' fees.  Notwithstanding the foregoing, any dispute relating Employee's obligations pursuant to Paragraphs 5, 6, and 7 above shall not be subject to the mediation/arbitration provisions set forth in this Paragraph 11.

12.    Agreement Binding Upon Successors.  This Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective successors, assigns, personal representatives, heirs, legatees and beneficiaries, provided, however, that Employee may not delegate his duties and obligations 

X-4 Page 4

Exhibit 10.53

hereunder to any other person, and further provided that no assignment of this Agreement by ART shall relieve ART of any of its obligations under the terms of this Agreement.

13.    Waiver of Breach.  The waiver of either party hereto of a breach of any provision of this Agreement shall not operate or be construed as a waiver of any subsequent breach by either ART or Employee.  The failure to enforce any provision(s) of this Agreement shall not be construed as a waiver of such provision(s).

14.    Severability.  It is the desire and intent of the Parties that the provisions of this Agreement be enforced to the fullest extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought.  Each provision of this Agreement or part thereof shall be severable.  If for any reason any provision or part thereof of this Agreement is finally determined to be invalid and contrary to, or in conflict with any existing or future law or regulation of a court or agency having valid jurisdiction, such determination shall not impair the operation or affect the remaining provisions of this Agreement, and such remaining provisions will continue to be given full force and effect and bind each party.

15.    Notices.  Any notices or other communications required or permitted to be given under this Agreement shall be in writing and shall be deemed to have been duly given if delivered personally, or sent by registered or certified mail, return receipt requested, postage prepaid, to the address listed below for the Parties, or to such other address as any party may hereafter direct in writing to the other party.

To ART:                            To Employee:
Chairman of the Board                    Salvatore Emma, Jr.
Arrhythmia Research Technology, Inc.            XXXXXXX
25 Sawyer Passway                        XXXXXXX
Fitchburg, MA 01420                            
                    
16.    Entire Agreement; Amendment.  This Agreement contains the entire agreement of the Parties and supersedes any and all prior agreements between the Parties.  It may not be changed orally but only by an agreement in writing signed by both Parties hereto.

17.    Governing Law.  This Agreement is made in, and shall be governed by, the laws of the Commonwealth of Massachusetts without reference to its conflict of laws provisions.

IN WITNESS WHEREOF, the Parties hereto, individually or by their duly authorized representatives, have executed and delivered this Agreement to be effective as of the day and year first above written.

ARRHYTHMIA RESEARCH TECHNOLOGY, INC.
By:/s/ E.P. Marinos
  Witness                               E.P. Marinos
       Chairman of the Board

EMPLOYEE
/s/ Salvatore Emma, Jr.
  Witness                                                              Salvatore Emma, Jr.

X-4 Page 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}]]